4-phenylpiperidines for the treatment of pruritic dermatoses
申请人:Pfizer Inc.
公开号:US06610711B2
公开(公告)日:2003-08-26
Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R1, R2, R3, W, Y1, Y2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment of pruritic dermatoses including allergic dermatitis and atopy in animals and humans.
4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURITIC DERMATOSES
申请人:PFIZER INC.
公开号:EP1077940A1
公开(公告)日:2001-02-28
US6610711B2
申请人:——
公开号:US6610711B2
公开(公告)日:2003-08-26
[EN] NOVEL 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURITIC DERMATOSES<br/>[FR] NOUVELLES 4-PHENYLPIPERIDINES DESTINEES AU TRAITEMENT DE DERMATOSES PRURIGINEUSES
申请人:PFIZER INC.
公开号:WO1999059971A1
公开(公告)日:1999-11-25
(EN) Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R1, R2, R3, W, Y1, Y2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment of pruritic dermatoses including allergic dermatitis and atopy in animals and humans.(FR) L'invention concerne de nouveaux composés de la formule générale (I) et leurs sels acceptables du point de vue pharmaceutique et vétérinaire. Dans ladite formule, R1, R2, R3, W, Y1, Y2, X, n et y sont tels que définis. L'invention concerne également des procédés de préparation desdits composés et des composés intermédiaires ainsi préparés. Ces nouveaux composés conviennent pour le traitement de dermatoses prurigineuses, y compris l'eczéma allergique et l'atopie chez l'homme et l'animal.
Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
申请人:——
公开号:US20030078282A1
公开(公告)日:2003-04-24
Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R 1, R 2, R 3, W, Y 1, Y 2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment. of pruritic dermatoses including allergic dermatitis and atopy in animals and humans